1. Introduction
Oxidative stress and advanced glycation end products (AGEs) are thought as causal factors of many diseases, such as diabetes, atherosclerosis, neurodegenerative disorders and aging. Therefore, the discovery of antioxidant and anti-AGEs molecules are important for preventing these age-related pathogenesis. Cadaba (Forssk.) is one of genera in the Capparaceae family, with about 30 species distributed in southern Africa, India, Malaysia, and Australia [1,2]. Among them four species grow in the Red Sea costal region in the Kingdom of Saudi Arabia [3]. Phytochemical studies of several Cadaba species led to isolation of various secondary metabolites, such as alkaloids, terpenoids and flavonoids [4,5,6,7]. Cadaba rotundifolia Forssk., known by the common name Qadab, is an erect shrub with numerous drooping branches with young twigs covered with short glandular hair [8]. In Sudan, C. rotundifolia roots and leaves are traditionally used to treat tumors and abscesses. A previous chemical study of the ethanolic extract of C. rotundifolia root yielded a quaternary alkaloid (3-hydroxystachydrine) [9]. However, no report on chemical constituents of the aerial parts of C. rotundifolia has been issued so far. In this work, we have investigated the chemical profile of the aerial parts of C. rotundifolia collected in Saudi Arabia. As a result, twenty flavonoids were obtained, including four undescribed acylated kaempferol glucosides 1–4 and 16 known compounds. This paper describes on the isolation, structural elucidation, and evaluation of antioxidant (DPPH) and inhibitory activity toward AGEs formation.
2. Results and Discussion
2.1. Isolation and Spectroscopic Analyses of the Compounds
The aerial parts of C. rotundifolia were extracted with MeOH at room temperature till exhausted. The MeOH extract (800 g) was further separated by solvent fractionation, various column chromatographies (CC), and HPLC to afford compounds 1–20 (Figure 1). The chemical structures of the isolated compounds were investigated and identified through intensive spectroscopic analyses based on UV-visible, 1D and 2D NMR, and HR-ESI-MS data as follows (Figures S1–S35).
2.1.1. Chemical Structure of Compound 1
Compound 1 was isolated as a yellow amorphous powder, soluble in MeOH with a negative optical rotation ([α]22D −79.0). Its molecular formula, C37H38O19, was determined by positive HR-ESI-MS analysis (m/z 809.1888 [M + Na]+,calcd for C37H38O19Na 809.1899). It had a UV spectrum typical of an acylated kaempferol glycoside (λmax 327, 267 nm) [10,11]. The IR spectrum suggested the presence of hydroxy (3388 cm−1), α,β-unsaturated carbonyl ester (1710 cm−1), α,β-unsaturated ketone (1658 cm−1), aromatic ring (1513, 1446 cm−1) and ether (1176, 1070 cm−1) functions. The proton and carbon resonances in its 1H and 13C-NMR spectra clarified the aromatic and glycosidic nature of 1. It was found that the 1H-NMR spectrum of 1 displayed feature resembling to those of 5 [12], as both the aglycone and glycoside units were almost identical. The major differences were in the signals related to the acyl group of 5. The 1H-NMR spectrum of 1 (Table 1) exhibited meta-coupled resonances at δH 6.17 and 6.37 (each 1H, d, J = 2.0 Hz), characteristic of H-6 and H-8 of the A-ring, respectively. The 1H–1H correlation spectrum (COSY, Figure 2) and 1H-NMR spectrum of 1 displayed two ortho-coupled doublet resonances at δH 8.01 and 6.91 (each 2H, d, J = 8.8 Hz) assignable to H-2′/6′ and H-3′/5′ of the B-ring, respectively, which indicated the presence of a kaempferol aglycone (Table 1).
The 1H-NMR spectrum of 1 (Table 1) also gave signals at δH 6.83 (1H, d, J = 8.2 Hz), 7.09 (1H, d, J = 8.2, 1.8 Hz) and 7.20 (1H, d, J = 1.8 Hz) attributable to an ABX coupling system for a 1,3,4-trisubstituted aromatic moiety, and two trans-coupled olefinic protons at δH 6.40 (1H, br d, J = 15.9 Hz) and 7.68 (1H, br d, J = 15.9 Hz), together with a singlet signal for a methoxy group at δH 3.92 which suggested the presence of a feruloyl or isoferuloyl function. The two anomeric proton resonances, which occur at δH 5.73 (1H, d, J = 8.0 Hz) and 4.43 (1H, d, J = 7.8 Hz) and 12 carbon signals (δc 104.9, 100.5, 84.9, 78.4, 78.1 , 77.7, 74.8, 74.6, 71.4, 70.0, 62.5 and 62.4) correspond to two glucose moieties. Acid hydrolysis of 1 released
According to the coupling constant of the olefinic protons at H-7′′′′ and H-8′′′′ (J = 15.9 Hz), the configuration of the feruloyl moiety was determined as trans. Full assignments of the 1H and 13C resonances of the structural fragments of 1 were achieved by analysis of COSY, HSQC and HMBC spectra. A correlation between the anomeric H-1′′ proton (δH 5.73) and δc 134.8 in the HMBC spectrum (Figure 2) defined C-3 of kaempferol as a site of O-glucosylation. Moreover, the interglucosidic linkage of the disaccharide moiety was also determined by the HMBC cross-peak between H-3′′ (δH 3.91) and C-1′′′ (δc 104.9). The E-feruloyl unit was linked to C-2′′ based on the correlations of the H-2′′ (δH 5.23) with C-1′′ (δc 100.5), C-3′′ (δc 84.9) and ester carbonyl carbon C-9′′′′ (δc 168.5). Therefore, the structure of compound 1 was determined as kaempferol 3-O-[2-O-(trans-feruloyl)-3-O-β-
2.1.2. Chemical Structure of Compound 2
Compound 2 was isolated as a yellow amorphous powder, with a positive optical rotation ([α] 22D +14.5). Its molecular formula was determined to be C48H56O27 by positive HR-ESI-MS (m/z 1087.2875 ([M + Na]+, calcd for C48H56O27Na 1087.2901). The UV profile of 2 displayed λmax 316, 267 nm, which was similar to those of the kaempferol glycoside acylated with a hydroxycinnamic acid [10,11,13]. The IR spectrum indicated absorptions of hydroxy (3397 cm−1), α,β-unsaturated carbonyl ester (1721 cm−1), α,β-unsaturated ketone (1657 cm−1), aromatic ring (1512, 1442 cm−1) and ether (1157, 1072 cm−1) functions. The above features were confirmed by the 1H-NMR spectrum which revealed a set of kaempferol signals, a p-coumaroyl group and glycoside moieties. The kaempferol aglycone of 2 was represented in the 1H-NMR spectrum (Table 1) by two ortho-coupled resonances of the B-ring at δH 8.06 and 6.89 (each 1H, d, J = 8.9 Hz), typical of H-2′/6′ and H-3′/5′, respectively, in addition to two meta-coupled proton resonances at δH 6.37 and 6.65 (each 1H, br s), attributed to H-6 and H-8 of the A-ring, respectively. In comparison with literature, the downfield shifts of H-6 and H-8 in the 1H-NMR spectrum suggested the presence of substitution at C-7 of kaempferol, while the substitution at C-3 was evident from the downfield shift of C-2 to δC 159.2 in the 13C-NMR spectrum. Moreover, the 1H-NMR spectrum (Table 1) exhibited two olefinic protons at δH 5.83 and 6.86 with a coupling constant of 12.9 Hz. Similarly, the AA′BB′ aromatic coupling system at δH 6.67 and 7.55 (each 1H, d, J = 8.6 Hz) were attributed to a p-coumaroyl unit, which was confirmed by the correlation of the olefinic protons (δH 5.83 and 6.86) with the ester carbonyl carbon at δc 167.2 and aromatic carbons (δC 127.6; C-1′′′′′′ and 133.4; C-2/6′′′′′′) in the HMBC spectrum (Figure 2). The sugar units in 2 were represented in the 1H-NMR spectra by four anomeric proton signals at δH 4.40 (1H, d, J = 7.8 Hz), 5.22 (1H, d, J = 1.3 Hz), 5.29 (1H, d, J = 7.8 Hz), 5.72 (1H, d, J = 7.6 Hz) and one methyl group at 0.96 (3H, d, J = 6.18 Hz), which indicated the tetraglycosidic nature of 2. Identification of the sugar residues was carried out by careful analysis of the 1D and 2D NMR data as well as comparison with the reported chemical shift values. The absolute stereochemistry of the sugars was determined by acid hydrolysis of 2 and HPLC analysis with an optical rotation detector, and the magnitudes of J1,2 coupling constants that revealed β-
2.1.3. Chemical Structure of Compound 3
Compound 3 was obtained as a yellow amorphous powder with a negative optical rotation ([α]22D −82.5). The molecular formula, C49H58O27, was deduced from the sodiated molecular ion peak at m/z 1101.3021 (calcd for C49H58O27Na 1101.3058) by HR-ESI-MS measurement. It displayed characteristic UV spectrum of an acylated kaempferol glycoside with λmax at 329, 268 nm, similar to those of 1. The IR spectrum exhibited absorptions of hydroxy (3389 cm−1), α,β-unsaturated ketone (1651 cm−1), aromatic ring (1513, 1455 cm−1) and ether (1180, 1071 cm−1) functions. Analysis of the 1H- and 13C-NMR spectra of 3 (Table 1 and Table 2) indicated the presence of a kaempferol residue, four hexose sugar moieties, and an E-feruloyl unit. The 1H spectrum (Table 1) displayed four downfield doublet signals at δH 6.46 (1H, d, J = 2.1 Hz), 6.61 (1H, d, J = 2.1 Hz), 6.76 (2 H, d, J = 8.9 Hz) and 7.93 (2 H, d, J = 8.9 Hz) assignable to H-6, 8, 3′/5′ and 2′/6′, respectively, belonging to kaempferol aglycone. Moreover, the characteristic signals of the E-feruloyl moiety were observed in 1H-NMR spectrum as five downfield doublets at δH 6.28 (1H, br d, J = 15.8 Hz), 6.67 (1H, d, J = 8.2 Hz), 6.85 (1H, d, J = 8.2, 1.7 Hz), 6.98 (1H, d, J = 1.7 Hz) and 7.50 (1H, br d, J = 15.8 Hz), corresponding to H-8′′′′′′, 5′′′′′′, 6′′′′′′, 2′′′′′′ and 7′′′′′′, respectively, in addition to a singlet signal of a methoxy group at δH 3.75. Full assignment of the 1D NMR spectra of 3 was achieved by analysis of COSY, HSQC and HMBC data, which confirmed presence of a 3,7-O-glycosidic kaempferol residue together with the E-feruloyl unit. Acid hydrolysis of 3 with 1 M HCl released
2.1.4. Chemical Structure of Compound 4
Compound 4 was isolated as a yellow amorphous powder, with a negative optical rotation ([α]22D −81.6). Its molecular formula was established as C48H56O26 by its positive HR-ESI-MS spectrum (m/z 1071.2925 [M + Na]+, calcd for C48H56O26Na 1071.2952), suggesting the lack of one methoxy group compared to 3. Analysis of 2D experiments of 4 including COSY, HSQC and HMBC, and comparison of its 1H- and 13C-NMR values with those of 3 (Table 1 and Table 2) showed that 4 was a kaempferol tetraglycoside acylated with a cinnamic acid derivative. The 1H- and 13C-NMR spectra of 4 revealed an identical glycosylation profile to that of 3. Comparison of the HMBC correlations of 4 with those of 3 (Figure 2) detected the same pattern of connectivity defining the linkages between the glycosyl moieties and the kaempferol residue, and between the glycosyl moieties themselves. Thus, the difference between 3 and 4 must be located at the acyl substituent. In particular, the 1H-NMR spectrum (Table 1) showed the typical coupling pattern (AA′BB′ system) of a 1,4-disubstituted aromatic moiety at δH 6.66 and 7.25 (each 2H, d, J = 8.6 Hz) and two trans-coupled double bond protons at δH 6.24 and 7.50 (each 1H, br d, J = 15.9 Hz), as well as to an ester carbonyl (δc 169.1) in the 13C-NMR spectrum assignable to a p-coumaroyl unit. In the HMBC spectrum (Figure 2), the cross peaks between H2-6′′′ (δH 4.18 and 4.54) and C-9′′′′′′ (δc 169.1) placed the p-coumaroyl unit at C-6′′′.The sugar units were identified as D-glucose and
2.2. Biological Activities of the Isolated Compounds
Isolated compounds 1–20 from the n-BuOH fraction of C. rotundifolia were evaluated for DPPH radical scavenging assay activity (Table 3) using Trolox as a positive control (IC50: 29.2 ± 0.39 µM). The results showed that compounds 17 and 18 exhibited potent radical scavenging activity with IC50 values of 14.5 and 11.7 µM, respectively. On the other hand, compounds 15 and 16 showed moderate activity with IC50 values of 43.0 and 31.8 µM, respectively. These results are consistent with previous studies on the effectiveness of myricetin as a potent antioxidant agent which could prevent and slow the progress of ageing or various diseases associated with oxidative stress.
Inhibitory effects of isolated compounds (1–20) on AGEs formation were also evaluated using a fluorescence method [14]. As shown in Table 3, compound 7 (IC50: 85.5 ± 3.5 µM), 17 (IC50: 96.5 ± 1.8 µM) and 18 (IC50: 34.9 ± 1.2 µM) showed strong inhibitory activity than that of a positive control, aminoguanidine hydrochloride (IC50: 7818 ± 34.4 µM). The results revealed that the most inhibitory effect was exhibited by myricetin (18). Comparison of IC50 values of myricetin (18) and its tri-, di-, and mono-glycosides (15, 16, and 17, respectively) indicated that the number of sugar moieties at C-3 of myricetin aglycone decreases the inhibition activity of AGEs formation. The other compounds did not show any inhibitory activity.
3. Materials and Methods
3.1. General Methods
Optical rotations were measured on a JASCO P-1030 polarimeter (Jasco, Tokyo, Japan). UV and IR spectra were obtained on a Jasco V-520 UV/Vis spectrophotometer and a Horiba FT-710 Fourier transform infrared spectrophotometer (Horiba, Kyoto, Japan), respectively. NMR experiments were measured on a Bruker Avance 500, 600 and 700 MHz spectrometers (Bruker, Billerica, MA, USA), with tetramethylsilane (TMS) as an internal standard. Positive ion HR-ESI-MS spectra were recorded using a LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Column chromatography (CC) was performed on Diaion HP-20 (Mitsubishi Chemical Corp., Tokyo, Japan), silica gel 60 (230–400 mesh, Merck, Darmstadt, Germany), and octadecyl silica (ODS) gel (Cosmosil 75C18-OPN (Nacalai Tesque, Kyoto, Japan; Φ = 35 mm, L = 350 mm), and TLC was performed on precoated silica gel plates 60 GF254 (0.25 mm in thickness, Merck). HPLC was performed on ODS gel (Inertsil ODS-3, GL-science, 10 mm × 250 mm, flow rate 2.5 mL/min) with a mixture of H2O, acetone and MeOH, and the eluate was monitored by refractive index and/or a UV detector. An amino column (Shodex Asahipak NH2P-50 4E (4.6 mm × 250 mm), CH3CN-H2O (3:1) 1 mL/min) together with a chiral detector (Jasco OR-2090plus) was used for HPLC analysis of sugars obtained after hydrolysis [15].
3.2. Plant Material
Aerial parts of Cadaba rotundifolia were collected from eastern region, near Makkah, Saudi Arabia, in April 2017. The collected plant was identified and classified by a plant taxonomist at Biology Department–Umm Al-Qura University, Makkah, Saudi Arabia. A voucher specimen (No. 15501) was deposited in the Herbarium of the Department of Pharmacognosy, Pharmacy College, King Saud University.
3.3. Extraction and Isolation
The air-dried powdered aerial parts (6.0 Kg) of C. rotundifolia Forssk. were extracted with MeOH (10 L × 7) and then concentrated under reduced pressure to give a viscous gummy material (800 g). This residue was suspended in 900 mL of distilled water and fractionated by shaking with petroleum ether (bp. 60–80 °C) (3L × 5, 132.9 g), CH2Cl2 (3 L × 5, 6 g), EtOAc (3 L × 5, 10.9 g) and n-BuOH (3 L × 5, 118 g), respectively. Part of n-BuOH fraction (112 g) was fractionated by Diaion HP-20 column chromatography (Φ = 6 cm, L = 35 cm, 900 g). The column was eluted initially with H2O, then with a MeOH/H2O stepwise gradient with increasing MeOH content (20, 40, 60, 80, 100% MeOH, respectively, 3 L each), yielding five fractions (Frs. Cr1–Cr5). The fraction Cr2 (10.7 g) was subjected to silica gel column chromatography (Φ = 3 cm, L = 15 cm, 100 g) eluting with increasing amount of MeOH in CHCl3 (20:1, 10:1, 7:1, 5:1, 3:1, 1:1, finally with 100% MeOH, 500 mL each) yielding seven fractions (Frs. Cr2.1–Cr2.7). Fraction Cr2.4 (3.5 g) was subjected to open reversed phase (ODS) column chromatography with a linear gradient of 10% aq. MeOH (400 mL)–100% methanol (400 mL), affording eight fractions (Frs. Cr2.4.1–Cr2.4.8). The residue of fraction Cr2.4.4 (187 mg) was purified by preparative HPLC using 46% aq. acetone to give 18 (5.0 mg) and 20 (25.1 mg). Fraction Cr2.5 (2.4 g) was subjected to ODS column chromatography eluting with a linear gradient of 10% aq. MeOH (400 mL)–100% MeOH (400 mL), to give seven fractions (Frs. Cr2.5.1–Cr2.5.7). The residue of fraction Cr2.5.4 (554 mg) was purified by preparative HPLC (25% aq. acetone) to give 6 (4.2 mg). Fraction Cr2.7 (2.6 g) was subjected to ODS column chromatography (linear gradient of 10% aq. MeOH (400 mL)–100% MeOH (400 mL), giving six fractions (Frs. Cr2.7.1–Cr2.7.6). The residue of fraction Cr2.7.2 (632 mg) was purified by preparative HPLC (25% aq. acetone) to give 15 (5.6 mg) and 16 (11.0 mg). Then residue of fraction Cr2.7.3 (1.2 g) was also purified by preparative HPLC (28% aq. acetone) to give 7 (17.3 mg) and 19 (9.2 mg). Fraction Cr3 (15.5 g) was subjected to silica gel column chromatography (Φ = 3 cm, L = 20 cm, 150 g) with increasing amounts of MeOH in CHCl3 (20:1, 10:1, 7:1, 5:1, 3:1, 1:1, then 100% MeOH, 400 mL each), yielding seven fractions (Frs. Cr3.1–Cr3.7). Fraction Cr3.3 (2.9 g) was subjected to ODS column chromatography (linear gradient of 10% aq. MeOH (400 mL)–100% MeOH (400 mL), affording nine fractions (Frs. Cr3.3.1–Cr3.3.9). The residue of fraction Cr3.3.4 (645 mg) was purified by preparative HPLC (28% aq. acetone) to give 10 (30.1 mg). Fraction Cr3.4 (2.8 g) was subjected to ODS column chromatography (linear gradient of 10% aq. MeOH (400 mL)–100% MeOH (400 mL)) leading to seven fractions (Frs. Cr3.4.1–Cr3.4.7). The residue of fraction Cr3.4.2 (1.2 g) was purified by preparative HPLC (28% aq. acetone) to give 17 (15.2 mg). The residue of fraction Cr3.4.4 (187 mg) was also purified by preparative HPLC (40% aq. acetone) to give 1 (7.4 mg) and 5 (2.0 mg). Fraction Cr3.5 (4.4 g) was subjected to ODS column chromatography (linear gradient of 10% aq. MeOH (400 mL)–100% MeOH (400 mL)) providing seven fractions (Frs. Cr3.5.1–Cr3.5.7). The residue of fraction Cr3.5.4 (692 mg) was purified by preparative HPLC (28% aq. acetone) to give 8 (39.0 mg) and 9 (20.0 mg). The other residue of fraction Cr3.5.5 (65.7 mg) was purified by preparative HPLC (32% aq. acetone) to give 11 (3.0 mg). Fraction Cr3.6 (760 mg) was subjected to ODS column chromatography (linear gradient of 10% aq. MeOH (400 mL)–100% MeOH (400 mL)), affording seven fractions (Frs. Cr3.6.1–Cr3.6.7). The residue of fraction Cr3.6.4 (923 mg) was purified by preparative HPLC (25% aq. acetone). The following compounds were separated: 2 (5.0 mg), 12 (12.0 mg), 13 (2.0 mg) and 14 (10.0 mg). The residue of fraction Cr3.6.5 (963 mg) was purified by preparative HPLC (35% aq. acetone) to give 3 (7.8 mg) and 4 (2.0 mg).
The known compounds 5–20 were identified by comparison of their spectroscopic data with those reported in the literature as kaempferol 3-O-[2-O-(trans-p-coumaroyl)-3-O-β-
3.4. Spectroscopic Data of Compounds 1–4
Kaempferol 3-O-[2-O-(trans-feruloyl)-3-O-β-
Yellow amorphous powder [α]22D −79.0 (c 0.42, MeOH); HR-ESI-MS: m/z: 809.1888 [M + Na]+ (calcd for C37H38O19Na 809.1899); UV λmax (MeOH) nm (log ɛ): 327 (4.21), 299 (4.12), 267 (4.13), 231 (4.23); IR (film) νmax: 3388, 2936, 1710, 1658, 1604, 1513, 1446, 1363, 1176, 1070, 1028 cm−1; 1H and 13C data see Table 1 and Table 2.
Kaempferol 3-O-β-neohesperidoside-7-O-[2-O-(cis-p-coumaroyl)-3-O-β-
Yellow amorphous powder [α]22D +14.5 (c 0.60, MeOH); HR-ESI-MS: m/z: 1087.2875 [M + Na]+ (calcd for C48H56O27Na 1087.2901); UV λmax (MeOH) nm (log ɛ): 351 (3.97), 316 (4.14), 267 (4.04), 229 (3.99); IR (film) νmax: 3397, 2924, 1721, 1657, 1603, 1512, 1442, 1367, 1157, 1072, 1024 cm−1; 1H and 13C data see Table 1 and Table 2.
Kaempferol 3-O-[2,6-di-O-α-
Yellow amorphous powder [α]22D −82.5 (c 1.02, MeOH); HR-ESI-MS: m/z: 1101.3026 [M + Na]+ (calcd for C49H58O27Na 1101.3058); UV λmax (MeOH) nm (log ɛ): 329 (4.17), 295 (4.00), 268 (4.05), 233 (4.11); IR (film) νmax: 3389, 2932, 1712, 1651, 1601, 1513, 1455, 1371, 1180, 1071, 1024 cm−1; 1H and 13C data see Table 1 and Table 2.
Kaempferol 3-O-[2,6-di-O-α-
Yellow amorphous powder [α]22D −81.6 (c 0.36, MeOH); HR-ESI-MS: m/z: 1071.2925 [M + Na]+ (calcd for C48H56O26Na 1071.2952); UV λmax (MeOH) nm (log ɛ): 348 (4.01), 317 (4.15), 267 (4.05), 228 (4.09); IR (film) νmax: 3379, 2912, 1660, 1601, 1499, 1445, 1372, 1172, 1074, 1034 cm−1; 1H and 13C data see Table 1 and Table 2.
3.5. Acid Hydrolysis
The isolated compounds 1–4 (1.0 mg each) were hydrolyzed with 1 M HCl (1.0 mL) at 80 °C for 3 h, then cooled. The reaction mixtures were neutralized with Amberlite IRA96SB (OH− form), then filtered to remove the resin. The filtrates were extracted with EtOAc. The aqueous layers were analyzed by HPLC with an amino column [Asahipak NH2P-50 4E, CH3CN-H2O (3:1), 1 mL/min] and a chiral detector (JASCO OR-2090plus) in comparison with authentic standards of D-glucose and L-rhamnose. The aqueous layers of the hydrolyzed compounds showed a peak at tR 8.15 min which coincided with that of
3.6. Alkaline Hydrolysis
Solutions of 1–3 (3.0 mg each) in 50% aqueous 1,4-dioxane (0.5 mL) were treated with 10% aqueous KOH (0.5 mL) and stirred at 37 °C for 1 h. The reaction mixtures were neutralized with an ion-exchange resin Amberlite IR-120B (H+-form), then filtered and evaporated. The residues were dissolved in EtOAc and subjected to HPLC analysis [Cosmosil C18-PAQ, MeOH-H2O (45:50), 1 mL/min)] with UV (245 nm) detection to identify ferulic acid (tR 16.7 min) from 1 and 3, and p-coumaric acid (tR 15.1 min) from 2 [22]. The authentic cis-p-coumaric acid was prepared according to the literature [23].
3.7. DPPH Radical Scavenging Activity
Free radical scavenging activity were evaluated by using a quantitative DPPH assay. The absorbance of various concentrations of test compounds dissolved in 100 µL of MeOH in 96-well microtiter plate were measured at 515 nm as (Ablank). Then, a 100 µL of DPPH solution (200 µM) was added to each well. The plate was incubated in dark chamber at room temperature for 30 min before measuring the absorbance (Asample) again. The following equation was used to calculate % inhibition of free radicals:
% Inhibition = [1 − (Asample − Ablank)/(Acontrol − Ablank)] × 100
where Acontrol is the absorbance of control (DMSO and all reagents, except the test compound). Their IC50 values were determined based on three independent experiments. Trolox was used as reference compound [24].3.8. Determination of In Vitro AGEs Formation
The reaction mixture including 0.5 M ribose and 10 mg/mL bovine serum albumin in 50 mM phosphate buffer (pH 7.4)- 0.02% sodium azide was mixed with the test compounds, and incubated for 24 h at 37 °C. The formation of fluorescent AGEs were measured with a fluorometric microplate reader (Ex: 370 nm, Em: 440 nm, EnSpire, PerkinElmer, Inc., Waltham, MA, USA). Experiments were performed in triplicate and IC50 values were calculated by linear regression [14].
4. Conclusions
In conclusion, four new flavonoid glycosides 1–4 together with 16 known compounds 5–20 were isolated from the aerial parts of Cadaba rotundifolia (Forssk.) (Qadab) collected in Saudi Arabia. The chemical structures of the new compounds were elucidated by intensive spectroscopic analyses and chemical reactions. Among the isolated compounds, 15–18 exhibited significant radical scavenging activity and compounds 7, 17 and 18 showed strong inhibitory activity toward AGEs formation. These results suggest that C. rotundifolia and their chemical constituents may ameliorate oxidative stress in various degenerative disorders including Alzheimer’s disease, diabetes, atherosclerosis and aging. Finally, it is noteworthy that most of the known compounds, 5–8, 11–16, 19, and 20, were isolated from the family Capparaceae for the first time. The remaining three known compounds, 9, 10, 17, also have not been isolated from the title plant so far. These results indicated that the characteristic circumstances of the oases surrounded by desert in Saudi Arabia provide promising and interesting natural resources for future drug development.
Supplementary Materials
The following are available online, Figures S1–S9: HR-ESI-MS, 1H, 13C NMR, DEPT, COSY, HSQC, HMBC, UV and IR spectra of 1, Figures S10–S18: Spectra of 2, Figures S19–S27: Spectra of 3, Figures S28–S35: Spectra of 4.
Author Contributions
K.M. and G.A.A.-H.; conceived and designed the experiment, G.A.A.-H.; implement the experiments, G.A.A.-H.; analyzed the data and wrote the original draft; K.M., S.S., and Y.Y.: helped in experiments and contributed reagents/material and analysis tools; K.M. and R.S.O., supervision, K.M.: write, review and editing; N.A. and A.M.A.: collection of plant.
Funding
This work was supported in part by King Saud University External Joint Supervision Program (EJSP), Kingdom of Saudi Arabia, and by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science (Nos. 17K15465 and 17K08336).
Acknowledgments
The measurements of NMR and HR-ESI-MS were performed with Bruker avance series and LTQ Orbitrap XL spectrometer, respectively, at the Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University. The other experimental facilities and useful suggestions for publication of this work was kindly supported by the research center in King Saud University.
Conflicts of Interest
The authors report no conflicts of interest.
Footnotes
Sample Availability: Samples of the compounds 1–4 are available from the authors.
Figures and Tables
Table 11H-NMR data of compounds 1–4 (600 or 700 * MHz, CD3OD, δ in ppm, J in Hz).
Position | 1 * | 2 | 3 | 4 | Position | 1 * | 2 | 3 | 4 |
---|---|---|---|---|---|---|---|---|---|
6 | 6.17 d (2.0) | 6.37 br s | 6.46 d (2.1) | 6.45 d (2.1) | 1′′′′ | - | 5.22 d (1.3) | 5.14 d (1.1) | 5.14 br s |
8 | 6.37 d (2.0) | 6.65 br s | 6.61 d (2.1) | 6.62 d (2.1) | 2′′′′ | 7.20 d (1.8) | 3.99 m | 3.90 m | 3.90 m |
2′ | 8.01 d (8.8) | 8.06 d (8.9) | 7.93 d (8.9) | 7.95 d (8.8) | 3′′′′ | - | 3.76 m | 3.69 m | 3.69 m |
3′ | 6.91 d (8.8) | 6.89 d (8.9) | 6.76 d (8.9) | 6.77 d (8.8) | 4′′′′ | - | 3.33 t (9.6) | 3.25 m | 3.42 m |
5′ | 6.91 d (8.8) | 6.89 d (8.9) | 6.76 d (8.9) | 6.77 d (8.8) | 5′′′′ | 6.83 d (8.2) | 4.02 dq (9.6, 6.18) | 3.93 dq (9.5, 6.2) | 3.68 dq (9.6, 6.2) |
6′ | 8.01 d (8.8) | 8.06 d (8.9) | 7.93 d (8.9) | 7.95 d (8.8) | 6′′′′ | 7.09 dd (8.2, 1.8) | 0.96 d (6.18) | 0.88 d (6.2) | 0.96 d (6.2) |
7′′′′ | 7.68 br d (15.9) | ||||||||
1′′ | 5.73 d (8.0) | 5.72 d (7.6) | 5.51 d (7.6) | 5.51 d (7.6) | 8′′′′ | 6.40 br d (15.9) | |||
2′′ | 5.23 dd (9.5, 8.0) | 3.60 m | 3.52 dd (9.6, 7.6) | 3.52 dd (9.6, 7.6) | OCH3 | 3.92 s | |||
3′′ | 3.91 t (9.5) | 3.55 t (9.0) | 3.45 m | 3.44 m | |||||
4′′ | 3.55 t (9.5) | 3.26 t (9.0) | 3.13 t (9.12) | 3.19 m | 1′′′′′ | 4.40 d (7.8) | 4.38 d (1.3) | 4.36 br s | |
5′′ | 3.39 ddd (9.5, 5.5, 2.0) | 3.31 m | 3.24 m | 3.24 m | 2′′′′′ | 3.20 dd (8.5, 7.8) | 3.38 m | 3.37 m | |
6′′ | 3.62 dd (12.0, 5.5) | 3.47 dd (12.0, 5.9) | 3.27 m | 3.27 m | 3′′′′′ | 3.31 m | 3.34 dd (9.4, 3.4) | 3.33 dd (9.4, 3.4) | |
3.81 dd (12.0, 2.0) | 3.71 dd (12.0, 2.1) | 3.71 m | 3.71 m | 4′′′′′ | 3.29 m | 3.12 t (9.4) | 3.25 m | ||
5′′′′′ | 3.22 m | 3.30 m | 3.25 m | ||||||
1′′′ | 4.43 d (7.8) | 5.29 d (7.8) | 4.98 d (7.4) | 4.98 d (7.3) | 6′′′′′ | 3.87 dd (11.5, 5.4) | 0.96 d (6.2) | 0.88 d (6.2) | |
2′′′ | 3.21 dd (8.8, 7.8) | 5.25 dd (9.0, 7.8) | 3.42 m | 3.41 t (9.4) | 3.64 dd (11.5, 1.3) | ||||
3′′′ | 3.31 t (8.8) | 3.92 t (9.0) | 3.43 m | 3.42 m | |||||
4′′′ | 3.28 t (8.8) | 3.76 m | 3.34 m | 3.34 t (9.4) | 2′′′′′′ | 7.55 d (8.6) | 6.98 d (1.7) | 7.25 d (8.6) | |
5′′′ | 3.34 m | 3.78 m | 3.72 m | 3.72 m | 3′′′′′′ | 6.67 d (8.6) | - | 6.66 d (8.6) | |
6′′′ | 3.62 dd (11.9, 2.2) | 3.75 dd (12.0, 5.1) | 4.17 dd (12.0, 2.0) | 4.18 dd (12.0, 2.1) | 5′′′′′′ | 6.67 d (8.6) | 6.67 d (8.2) | 6.66 d (8.6) | |
3.88 dd (11.9, 6.0) | 3.94 dd (12.0, 1.6) | 4.57 dd (12.0, 6.9) | 4.54 dd (12.0, 7.0) | 6′′′′′′ | 7.55 d (8.6) | 6.85 d (8.2, 1.7) | 7.25 d (8.6) | ||
7′′′′′′ | 6.86 br d (12.9) | 7.50 br d (15.8) | 7.50 br d (15.9) | ||||||
8′′′′′′ | 5.83 br d (12.9) | 6.28 br d (15.8) | 6.24 br d (15.9) | ||||||
OCH3 | 3.75 s |
m: multiplet or overlapped signals.
Table 213C-NMR data of compounds 1–4 (150 or 175 * MHz, CD3OD, δ in ppm).
Position | 1 * | 2 | 3 | 4 | Position | 1 * | 2 | 3 | 4 |
---|---|---|---|---|---|---|---|---|---|
2 | 158.4 | 159.2 | 159.4 | 159.4 | 1′′′′ | 127.8 | 102.6 | 102.5 | 102.5 |
3 | 134.8 | 134.7 | 134.6 | 134.6 | 2′′′′ | 111.7 | 72.4 | 72.3 | 72.3 |
4 | 179.2 | 179.5 | 179.5 | 179.5 | 3′′′′ | 149.3 | 72.3 | 72.3 | 72.3 |
5 | 163.2 | 163.0 | 162.9 | 162.9 | 4′′′′ | 150.6 | 74.0 | 74.0 | 74.7 |
6 | 99.8 | 100.4 | 100.7 | 100.7 | 5′′′′ | 116.4 | 69.9 | 69.9 | 69.9 |
7 | 165.8 | 163.8 | 164.4 | 164.4 | 6′′′′ | 124.3 | 17.6 | 17.6 | 17.6 |
8 | 94.6 | 95.7 | 96.3 | 96.2 | 7′′′′ | 147.5 | |||
9 | 158.5 | 157.9 | 157.8 | 157.8 | 8′′′′ | 115.5 | |||
10 | 105.8 | 108.0 | 107.7 | 107.7 | 9′′′′ | 168.5 | |||
1′ | 122.7 | 122.8 | 122.8 | 122.8 | OCH3 | 56.4 | |||
2′ | 132.2 | 132.3 | 132.2 | 132.2 | |||||
3′ | 116.3 | 116.2 | 116.2 | 116.9 | 1′′′′′ | 105.0 | 102.2 | 102.2 | |
4′ | 161.6 | 161.6 | 161.4 | 161.5 | 2′′′′′ | 74.7 | 72.0 | 72.0 | |
5′ | 116.3 | 116.2 | 116.2 | 116.9 | 3′′′′′ | 77.8 | 72.0 | 72.0 | |
6′ | 132.2 | 132.3 | 132.2 | 132.2 | 4′′′′′ | 71.4 | 73.8 | 74.0 | |
5′′′′′ | 78.9 | 69.7 | 69.7 | ||||||
1′′ | 100.5 | 100.2 | 100.3 | 100.3 | 6′′′′′ | 62.5 | 17.8 | 17.8 | |
2′′ | 74.6 | 80.0 | 79.7 | 79.8 | |||||
3′′ | 84.9 | 78.9 | 79.0 | 79.0 | 1′′′′′′ | 127.6 | 127.6 | 127.1 | |
4′′ | 70.0 | 71.8 | 72.0 | 71.7 | 2′′′′′′ | 133.4 | 111.6 | 131.2 | |
5′′ | 78.4 | 78.1 | 77.2 | 77.2 | 3′′′′′′ | 115.9 | 149.2 | 116.2 | |
6′′ | 62.4 | 62.6 | 68.3 | 68.3 | 4′′′′′′ | 160.0 | 150.5 | 161.2 | |
5′′′′′′ | 115.9 | 116.5 | 116.2 | ||||||
1′′′ | 104.9 | 99.6 | 101.6 | 101.6 | 6′′′′′′ | 133.4 | 124.2 | 131.2 | |
2′′′ | 74.8 | 73.4 | 74.7 | 73.8 | 7′′′′′′ | 145.0 | 147.3 | 147.1 | |
3′′′ | 77.7 | 84.3 | 77.8 | 77.8 | 8′′′′′′ | 116.6 | 115.1 | 114.7 | |
4′′′ | 71.4 | 69.8 | 71.7 | 71.8 | 9′′′′′′ | 167.2 | 169.1 | 169.1 | |
5′′′ | 78.1 | 78.2 | 75.8 | 75.7 | OCH3 | 56.5 | |||
6′′′ | 62.5 | 62.2 | 64.6 | 64.6 |
Bioactivities of 7 and 15–18 from C. rotundifolia.
Isolated Compounds | DPPH (IC50, µM) | AGEs (IC50, µM) |
---|---|---|
Kaempferol 3-O-[2,6-di-O-α- |
>100 | 85.5 ± 3.5 |
Myricetin 3-O-[2,6-di-O-α- |
43.0 ± 1.15 | >100 |
Myricetin 3-O-β-neohesperidoside (16) | 31.8 ± 0.63 | >100 |
Myricetin 3-O-β- |
14.5 ± 1.15 | 96.5 ± 1.8 |
Myricetin (18) | 11.7 ± 1.8 | 34.9 ± 1.2 |
Trolox | 29.2 ± 0.39 | n.d. |
Aminoguanidine hydrochloride | n.d. | 7818 ± 34.4 |
n.d.: not determined.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2019 by the authors.
Abstract
Cadaba rotundifolia (Forssk.) (family: Capparaceae; common name: Qadab) is one of four species that grow in the Red Sea costal region in the Kingdom of Saudi Arabia. The roots and leaves of C. rotundifolia is traditionally used to treat tumors and abscesses in Sudan. A previous phytochemical study of the roots yielded a quaternary alkaloid, but no report on chemical constituents of the aerial parts of the C. rotundifolia growing in Saudi Arabia has been issued so far. Oxidative stress and advanced glycation end products (AGEs) are thought as causal factors in many degenerative diseases, such as Alzheimer’s disease, diabetes, atherosclerosis and aging. In this study, a total of twenty compounds, including four previously undescribed acylated kaempferol glucosides, were isolated from the aerial parts of C. rotundifolia collected in Saudi Arabia. These new compounds were identified as kaempferol 3-O-[2-O-(trans-feruloyl)-3-O-β-
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Department of Pharmacognosy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan; Department of Pharmacognosy, College of Pharmacy, King Saud University, 11495 Riyadh, Saudi Arabia
2 Department of Pharmacognosy, College of Pharmacy, King Saud University, 11495 Riyadh, Saudi Arabia
3 Department of Pharmacognosy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
4 Department of Biology, Umm Al-Qura University, 1109 Makkah Al-Mukarramah, Saudi Arabia
5 Department of Biology, Arts and Sciences in Qilwah, Al-Baha University, 1988 Al-Baha, Saudi Arabia